Literature DB >> 11264183

Evidence for linkage of familial Diamond-Blackfan anemia to chromosome 8p23.3-p22 and for non-19q non-8p disease.

H Gazda1, J M Lipton, T N Willig, S Ball, C M Niemeyer, G Tchernia, N Mohandas, M J Daly, A Ploszynska, K A Orfali, A Vlachos, B E Glader, R Rokicka-Milewska, A Ohara, D Baker, D Pospisilova, A Webber, D H Viskochil, D G Nathan, A H Beggs, C A Sieff.   

Abstract

Diamond-Blackfan anemia (DBA) is a rare congenital hypoplastic anemia that usually presents early in infancy and is inherited in 10% to 20% of cases. Linkage analysis has shown that DBA in many of both dominant and recessive DBA families mapped to chromosome 19q13.2 leading to the cloning of a gene on chromosome 19q13.2 that encodes a ribosomal protein, RPS19. However, subsequently, mutations of the RPS19 gene have only been identified in 25% of all patients with DBA. This study analyzed 14 multiplex DBA families, 9 of which had 19q13.2 haplotypes inconsistent with 19q linkage. A genome-wide search for linked loci suggested the presence of a second DBA locus in a 26.4-centimorgan (cM) interval on human chromosome 8p. Subsequently, 24 additional DBA families were ascertained and all 38 families were analyzed with additional polymorphic markers on chromosome 8p. In total, 18 of 38 families were consistent with linkage to chromosome 8p with a maximal LOD score with heterogeneity of 3.55 at D8S277 assuming 90% penetrance. The results indicate the existence of a second DBA gene in the 26.4-cM telomeric region of human chromosome 8p23.3-p22, most likely within an 8.1-cM interval flanked by D8S518 and D8S1825. Seven families were inconsistent with linkage to 8p or 19q and did not reveal mutations in the RPS19 gene, suggesting further genetic heterogeneity. (Blood. 2001;97:2145-2150)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264183     DOI: 10.1182/blood.v97.7.2145

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Mutations in the ribosomal protein genes in Japanese patients with Diamond-Blackfan anemia.

Authors:  Yuki Konno; Tsutomu Toki; Satoru Tandai; Gang Xu; Runan Wang; Kiminori Terui; Shouichi Ohga; Toshiro Hara; Asahito Hama; Seiji Kojima; Daiichiro Hasegawa; Yoshiyuki Kosaka; Ryu Yanagisawa; Kenichi Koike; Rie Kanai; Tsuyoshi Imai; Teruaki Hongo; Myoung-Ja Park; Kanji Sugita; Etsuro Ito
Journal:  Haematologica       Date:  2010-04-07       Impact factor: 9.941

2.  Disorders of sex development and Diamond-Blackfan anemia: is there an association?

Authors:  Julia Hoefele; Anne-Marie Bertrand; Maximilian Stehr; Thierry Leblanc; Gil Tchernia; Maud Simansour; Brigitte Mignot; Martin Alberer; Hans-Peter Schwarz; Lydie Da Costa
Journal:  Pediatr Nephrol       Date:  2010-04-01       Impact factor: 3.714

3.  Normalization of red cell enolase level following allogeneic bone marrow transplantation in a child with Diamond-Blackfan anemia.

Authors:  Jeong A Park; Yeon Jung Lim; Hyeon Jin Park; Sun Young Kong; Byung Kiu Park; Thad T Ghim
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

Review 4.  Untangling the phenotypic heterogeneity of Diamond Blackfan anemia.

Authors:  Jason E Farrar; Niklas Dahl
Journal:  Semin Hematol       Date:  2011-04       Impact factor: 3.851

5.  Targeted disruption of the ribosomal protein S19 gene is lethal prior to implantation.

Authors:  Hans Matsson; Edward J Davey; Natalia Draptchinskaia; Isao Hamaguchi; Andreas Ooka; Per Levéen; Erik Forsberg; Stefan Karlsson; Niklas Dahl
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

6.  An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray.

Authors:  Benjamin L Ebert; Michele M Lee; Jennifer L Pretz; Aravind Subramanian; Raymond Mak; Todd R Golub; Colin A Sieff
Journal:  Blood       Date:  2005-03-08       Impact factor: 22.113

7.  Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.

Authors:  Shouichi Ohga; Hideo Mugishima; Akira Ohara; Seiji Kojima; Kohji Fujisawa; Keiko Yagi; Masamune Higashigawa; Ichiro Tsukimoto
Journal:  Int J Hematol       Date:  2004-01       Impact factor: 2.490

8.  Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita.

Authors:  Blanche P Alter; Gabriela M Baerlocher; Sharon A Savage; Stephen J Chanock; Babette B Weksler; Judith P Willner; June A Peters; Neelam Giri; Peter M Lansdorp
Journal:  Blood       Date:  2007-04-27       Impact factor: 22.113

9.  Obsessive compulsive disorder comorbidity in DBA.

Authors:  Stefano Pallanti; Sara Masetti; Silvia Bernardi; Alice Innocenti; Mariana Markella; Eric Hollander
Journal:  Clin Pract Epidemiol Ment Health       Date:  2008-03-10

10.  Bone marrow failure may be caused by chromosome anomalies exerting effects on RUNX1T1 gene.

Authors:  R Valli; L Vinti; A Frattini; M Fabbri; G Montalbano; C Olivieri; A Minelli; F Locatelli; F Pasquali; E Maserati
Journal:  Mol Cytogenet       Date:  2018-01-11       Impact factor: 2.009

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.